On #2 I have seen low dose naltrexone work really well which is amusing given its counterintuitive nature as an opioid antagonist. This was a fun puzzle to think about.
My current best guess on how it work starts with the fact that when taken in low doses that only last a few hours it results in upregulation of the opioid receptors. A high level pathway you have for pain and turning off the pain would be:
Pain stimulates nociceptors => increased substance P => increased cytokines, chemokines, etc => increased T-lymphocyte => increased β-endorphins => inhibit substance P
So with LDN less β-endorphins is needed to "turn off the pain" and you now get a shorter pain on / pain off cycle or really a shorter substance P cycle.
It's obvious first use is when the opioid receptors have been down regulated, but it has lots of extra benefits for instance, the immune response is time limited to the necessary duration of pain, reducing the likelihood of autoimmune complications. Additionally, diminished cytokine levels result in less hypothalamic activation, mitigating excessive appetite (not to mention better TRH response). This helps many with fibromyalgia may struggle with weight management. Numerous other secondary effects have been documented over time (last 40ish years), underscoring the multifaceted impact of low-dose naltrexone.
However, I agree that it is crucial to acknowledge that while this can effectively alleviate symptoms, it may also mask underlying issue(s). That could be something as simple as Zinc deficiency (due to diet or genetic predisposition) or more complicated such as classic like EDS.